fda warns against semaglutide compounded versions of Ozempic, Mounjaro FDA Adds New Warning to

The right option depends on your health needs, treatment goals and your providers guidance

A 2022 trial showed patients regained two-thirds of their weight loss within one year of stopping semaglutide Other Key Considerations Pre-op guidance: Most patients should continue taking their glucagon-like peptide-1 (GLP-1) receptor agonists before elective surgery

GHK-Cu is not a controlled substance in the UK and can be legally supplied for laboratory research purposes only

Aligns nutrition with appetite changes caused by GLP-1 medications

Consult with a qualified healthcare provider before beginning any peptide supplementation protocol.